Medicare Enrolled
Dr. Jonathan Thomas, MD
Rheumatology · Texarkana, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Thomas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thomas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Thomas
Dr. Jonathan Thomas is a rheumatology specialist in Texarkana, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Thomas performed 16,159 Medicare services across 1,917 unique beneficiaries.
Between the years covered by Open Payments, Dr. Thomas received a total of $4,510 from 51 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Thomas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 33% volume in TX
$4,510 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,159
Medicare services
Top 33% in TX for rheumatology
1,917
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~808 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
10,250 | $34 | $90 |
| Denosumab injection (Prolia/Xgeva) | 1,800 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
742 | $88 | $245 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
526 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
525 | $8 | $48 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
522 | $10 | $105 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
442 | $5 | $23 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
441 | $3 | $26 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
256 | $45 | $168 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
173 | $10 | $42 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $62 | $175 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
54 | $13 | $100 |
| Injection, methylprednisolone acetate, 40 mg | 50 | $6 | $21 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
38 | $29 | $250 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
38 | $6 | $29 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
32 | $20 | $60 |
| New patient office visit, complex (60-74 min) | 30 | $149 | $420 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
25 | $9 | $52 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
25 | $16 | $86 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
24 | $3 | $28 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
24 | $13 | $58 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
22 | $4 | $24 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
17 | $5 | $22 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
17 | $4 | $24 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $127 | $315 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $30 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
65.0% high complexity
12.5% medium
22.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,510
Total received (2018-2024)
Avg $644/year across 7 years
Top 48% in TX for rheumatology
51
Companies
275
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,401 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$592
2023
$573
2022
$839
2021
$345
2020
$678
2019
$714
2018
$769
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$831
UCB, Inc.
$541
Janssen Biotech, Inc.
$430
Novartis Pharmaceuticals Corporation
$374
AbbVie, Inc.
$231
Regeneron Healthcare Solutions, Inc.
$226
Lilly USA, LLC
$187
PFIZER INC.
$153
GlaxoSmithKline, LLC.
$136
Otsuka America Pharmaceutical, Inc.
$105
AstraZeneca Pharmaceuticals LP
$94
Seagen Inc.
$89
Incyte Corporation
$89
Actelion Pharmaceuticals US, Inc.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Celgene Corporation
$56
Merck Sharp & Dohme Corporation
$53
Genentech USA, Inc.
$48
Jazz Pharmaceuticals Inc.
$48
Taiho Oncology, Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$46
United Therapeutics Corporation
$36
Janssen Pharmaceuticals, Inc
$35
GENZYME CORPORATION
$31
Aurinia Pharma U.S., Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$25
Sobi, Inc
$25
AMAG Pharmaceuticals, Inc.
$24
Horizon Therapeutics plc
$22
Daiichi Sankyo Inc.
$22
Edwards Lifesciences Corporation
$21
Adaptive Biotechnologies Corporation
$21
Clovis Oncology, Inc.
$21
TerSera Therapeutics LLC
$19
Secura Bio, Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$19
Rigel Pharmaceuticals, Inc.
$19
MACROGENICS, INC.
$18
ABBVIE INC.
$18
Octapharma USA, Inc.
$17
Blueprint Medicines Corporation
$16
Puma Biotechnology, Inc.
$16
Epizyme, Inc.,
$16
Sun Pharmaceutical Industries Inc.
$14
Acceleron Pharma, Inc.
$14
EMD Serono, Inc.
$14
Janssen Scientific Affairs, LLC
$13
Ipsen Biopharmaceuticals, Inc
$13
ADC Therapeutics America, Inc.
$12
Array BioPharma Inc.
$12
Stemline Therapeutics Inc.
$11
Top 3 companies account for 39.9% of total payments
Associated products mentioned in payments ›
AYVAKIT · BENLYSTA · BYNFEZIA PEN · Bimzelx · Braftovi · COSENTYX · Cimzia · DARZALEX · DOPTELET · DUPIXENT · ELITEK · ELZONRIS · ENHERTU · ERLEADA · EUCRISA · EVENITY · EVUSHELD · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Enbrel · Erleada · FARYDAK · FERAHEME · FORTEO · Horizant · Humira · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · Inrebic · JAKAFI · JYNARQUE · KANJINTI · KEVZARA · KEYTRUDA · KISQALI · KRYSTEXXA · Kerendia · Kyprolis · LIBTAYO · LONSURF · LUPKYNIS · Lonsurf · MARGENZA · MONJUVI · MVASI · NERLYNX · NINLARO · NUCALA · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Otezla · PADCEV · PEMAZYRE · PROMACTA · Pomalyst · RINVOQ · Reblozyl · Revlimid · Rituxan · Rubraca · SAMSCA · SAPHNELO · SIMPONI ARIA · SOMATULINE DEPOT · STELARA · TALTZ · TAVNEOS · TAZVERIK · TREMFYA · TUKYSA · Tavalisse · Tavneos · UPTRAVI · VYXEOS · XARELTO · XELJANZ · Xofigo · Xyrem · ZEJULA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $28 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
1
Per 100K population
1.1
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Thomas is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Thomas experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Thomas performed 10,250 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thomas receive payments from pharmaceutical companies?
Yes. Dr. Thomas received a total of $4,510 from 51 companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thomas's costs compare to other rheumatologists in Texarkana?
Dr. Thomas's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thomas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Texarkana
Browse rheumatologists in Texarkana ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology